TRCT
MGNX icon

Tower Research Capital (TRC)’s MacroGenics MGNX Stock Holding History

Tower Research Capital (TRC)’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-978
Closed -$1.57K – 5381
2025
Q4 		$1.57K Sell
978
-15,785
-94% -$24.8K ﹤0.01% 4674
2025
Q3 		$28.2K Sell
16,763
-3,916
-19% -$6.34K ﹤0.01% 3002
2025
Q2 		$25K Sell
20,679
-1,582
-7% -$2.29K ﹤0.01% 3537
2025
Q1 		$28.3K Buy
22,261
+18,795
+542% +$49.1K ﹤0.01% 2662
2024
Q4 		$11.3K Buy
3,466
+479
+16% +$1.73K ﹤0.01% 3735
2024
Q3 		$9.83K Sell
2,987
-14,357
-83% -$55.9K ﹤0.01% 3829
2024
Q2 		$73.7K Buy
17,344
+14,360
+481% +$140K ﹤0.01% 2810
2024
Q1 		$43.9K Sell
2,984
-21,381
-88% -$323K ﹤0.01% 2373
2023
Q4 		$234K Buy
24,365
+15,841
+186% +$110K ﹤0.01% 1965
2023
Q3 		$39.7K Buy
8,524
+3,628
+74% +$18.1K ﹤0.01% 2746
2023
Q2 		$26.2K Buy
4,896
+881
+22% +$5.43K ﹤0.01% 3146
2023
Q1 		$29K Buy
4,015
+590
+17% +$3.55K ﹤0.01% 3037
2022
Q4 		$23K Sell
3,425
-650
-16% -$3.56K ﹤0.01% 2999
2022
Q3 		$14K Sell
4,075
-20,583
-83% -$78.7K ﹤0.01% 4217
2022
Q2 		$73K Buy
24,658
+8,270
+50% +$43.5K ﹤0.01% 2538
2022
Q1 		$145K Buy
16,388
+7,586
+86% +$83.7K ﹤0.01% 1966
2021
Q4 		$142K Buy
8,802
+3,143
+56% +$59.2K ﹤0.01% 2004
2021
Q3 		$118K Buy
5,659
+2,145
+61% +$51.7K ﹤0.01% 2256
2021
Q2 		$94K Sell
3,514
-468
-12% -$13.7K ﹤0.01% 2476
2021
Q1 		$127K Buy
3,982
+2,713
+214% +$65.9K ﹤0.01% 2390
2020
Q4 		$29K Sell
1,269
-955
-43% -$22K ﹤0.01% 3597
2020
Q3 		$56K Sell
2,224
-4,215
-65% -$115K ﹤0.01% 3490
2020
Q2 		$180K Buy
+6,439
New +$112K 0.01% 1882
2019
Q4 		– Sell
-7,374
Closed -$94K – 4050
2019
Q3 		$94K Buy
+7,374
New +$106K 0.01% 1385
2019
Q2 		– Sell
-4,846
Closed -$87K – 4039
2019
Q1 		$87K Buy
4,846
+4,746
+4,746% +$82K 0.01% 1496
2018
Q4 		$1K Buy
+100
New +$1.68K ﹤0.01% 3621
2018
Q2 		– Sell
-659
Closed -$17K – 3900
2018
Q1 		$17K Sell
659
-128
-16% -$3.11K ﹤0.01% 2250
2017
Q4 		$15K Sell
787
-1,681
-68% -$31.4K ﹤0.01% 2273
2017
Q3 		$46K Buy
2,468
+2,358
+2,144% +$40.8K ﹤0.01% 2047
2017
Q2 		$2K Buy
+110
New +$2.1K ﹤0.01% 2346
2016
Q3 		– Sell
-153
Closed -$4K – 4108
2016
Q2 		$4K Sell
153
-247
-62% -$5.57K ﹤0.01% 3536
2016
Q1 		$8K Sell
400
-25
-6% -$476 ﹤0.01% 2213
2015
Q4 		$13K Buy
+425
New +$12.9K ﹤0.01% 1796
2015
Q3 		– Sell
-1,091
Closed -$42K – 4467
2015
Q2 		$42K Sell
1,091
-1,083
-50% -$35.6K ﹤0.01% 1506
2015
Q1 		$68K Buy
+2,174
New +$73.7K 0.01% 1221
2014
Q4 		– Sell
-2
Closed – – 4408
2014
Q3 		$0 Sell
2
-388
-99% -$8.03K ﹤0.01% 4700
2014
Q2 		$8K Sell
390
-1,193
-75% -$25.1K ﹤0.01% 2524
2014
Q1 		$44K Buy
+1,583
New +$55.9K 0.01% 1191

Other funds holding MGNX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Tower Research Capital (TRC)'s MGNX Position: Q1 2026 in Review

Tower Research Capital (TRC) sold out of MacroGenics (MGNX) in Q1 2026, closing a stake of 978 shares — an estimated $1.57K sold.

Tower Research Capital (TRC) first reported a position in MGNX in Q1 2014 and held it in 38 quarters. The position peaked at $234K in Q4 2023. 109 funds tracked by Wall St. Rank hold MGNX as of Q1 2026.

  • Tower Research Capital (TRC) reported no remaining MacroGenics position as of Q1 2026 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 978 MacroGenics shares in Q1 2026, an estimated $1.57K.
  • Tower Research Capital (TRC) first reported a position in MacroGenics in Q1 2014 and held it in 38 quarters.
  • Tower Research Capital (TRC)'s MacroGenics position peaked at $234K in Q4 2023.
  • 109 funds tracked by Wall St. Rank held MacroGenics as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.